Skip to main content

Resmed Inc(RMD-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low162.05
Day High164.74
Open:163.84
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
The Globe and Mail
What’s the Ozempic effect on the stock market?
GlobeNewswire
ResMed Adopts New Operating Model to Accelerate Long-term Growth
Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
Barchart
Markets Today: Stocks Erase Overnight Gains on a Strong Sep CPI Report
Barchart
Stocks Settle Higher as Bond Yields Fall on Dovish Fed Comments
Barchart
Stocks Mixed as Dovish Fed Comments Knock Bond Yields Lower
Barchart
Markets Today: Stocks Fall and Bond Yields Jump as U.S. Payrolls Surge
Barchart
Stocks Fade Early Gains on Hawkish Fed Comments
Barchart
Stocks Settle Mixed as Bond Yields Grind Higher
Barchart
Stocks Give Up Early Gains as Bond Yields Resume Their Climb
Barchart
Markets Today: Stocks Gain on Lower Bond Yields
Barchart
Stocks Tumble as Confidence in the U.S. Economic Outlook Wanes
Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
Motley Fool
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
Motley Fool
3 Growth Stocks That Can Soar 50%, According to Wall Street
Motley Fool
2 Stocks That Could Grow Your Portfolio Over the Next Decade
Barchart
Stocks Dragged Lower by Losses in Apple
Barchart
Stocks Move Lower After a Rocky Week of Trading
Barchart
Markets Today: Stocks Climb on Strong Amazon Earnings and Lower Bond Yields
Barchart
Markets Today: Stocks Fall on Disappointing Earnings Results
GlobeNewswire
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
GlobeNewswire
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
Barchart
Strong Earnings Results Boost Stocks
Barchart
Stocks Push Higher on Strength in Corporate Earnings
Motley Fool
3 Incredible Growth Stocks to Buy Right Now
Motley Fool
Company Report Roundup: Tesla, Tractor Supply, American Express, and More
Motley Fool
ResMed (RMD) Q4 2022 Earnings Call Transcript
Baystreet
Light Week for Economic News
Globe Newswire
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
Globe Newswire
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
Globe Newswire
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
Globe Newswire
ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference

Profile

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.